scholarly journals Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

2020 ◽  
Author(s):  
Yanjun Zhang ◽  
Gang Zeng ◽  
Hongxing Pan ◽  
Changgui Li ◽  
Yaling Hu ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase 1 ◽  
Healthy Adults ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial

2020 ◽  
Vol 20 (4) ◽  
pp. 455-466 ◽  
Author(s):  
David K Clarke ◽  
Rong Xu ◽  
Demetrius Matassov ◽  
Theresa E Latham ◽  
Ayuko Ota-Setlik ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Virus Vaccine ◽  
Ebola Virus ◽  
Phase 1 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Phase 1 Clinical Trial

scholarly journals Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

2016 ◽  
Vol 16 (3) ◽  
pp. 311-320 ◽  
Author(s):  
Olga De Santis ◽  
Régine Audran ◽  
Emilie Pothin ◽  
Loane Warpelin-Decrausaz ◽  
Laure Vallotton ◽  
...  
Keyword(s):  
Phase 1 ◽  
Healthy Adults ◽  
Dose Finding ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial

2016 ◽  
Vol 16 (3) ◽  
pp. 303-310 ◽  
Author(s):  
Larisa Rudenko ◽  
Irina Isakova-Sivak ◽  
Anatoly Naykhin ◽  
Irina Kiseleva ◽  
Marina Stukova ◽  
...  
Keyword(s):  
Influenza Vaccine ◽  
Phase 1 ◽  
Healthy Adults ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Phase 1 Trial ◽  
Live Attenuated Influenza Vaccine
Sign in / Sign up

Export Citation Format

Share Document